A francisella tularensis SCHU S4 mutant deficient in γ-glutamyltransferase activity induces protective immunity: Characterization of an attenuated vaccine candidate

Microbiology

Volumn 157, Issue 11, 2011, Pages 3172-3179

  Ireland, Philip M ^a   Lebutt, Helen ^a   Thomas, Rebecca M ^a   Oyston, Petra C F ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CYSTEINE; GAMMA GLUTAMYLTRANSFERASE; LIVE VACCINE; SCHU S4 VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FRANCISELLA TULARENSIS; GENE DELETION; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MICROBIAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TULAREMIA;

ANIMALS; BACTERIAL VACCINES; CELL LINE; FEMALE; FRANCISELLA TULARENSIS; GAMMA-GLUTAMYLTRANSFERASE; GENETIC COMPLEMENTATION TEST; MACROPHAGES; MICE; MICE, INBRED BALB C; SEQUENCE DELETION; TULAREMIA; VACCINES, ATTENUATED; VIRULENCE;

FRANCISELLA TULARENSIS; MURINAE;

EID: 80155132441     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.052902-0     Document Type: Article

References (59)

1. Alkhuder, K., Meibom, K. L., Dubail, I., Dupuis, M. & Charbit, A. (2009). Glutathione provides a source of cysteine essential for intracellular multiplication of Francisella tularensis. PLoS Pathog 5, e1000284.
2. Ark, N. M. & Mann, B. J. (2011). Impact of Francisella tularensis pilin homologs on pilus formation and virulence. Microb Pathog 51, 110-120.
3. Atlas, R. M. (2004). Handbook of Microbiological Media. Boca Raton, FL: CRC Press.
4. Barnes, I. H., Bagnall, M. C., Browning, D. D., Thompson, S. A., Manning, G. & Newell, D. G. (2007). γ-Glutamyl transpeptidase has a role in the persistent colonization of the avian gut by Campylobacter jejuni. Microb Pathog 43, 198-207.
5. Bina, X. R., Lavine, C. L., Miller, M. A. & Bina, J. E. (2008). The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice. FEMS Microbiol Lett 279, 226-233.
6. Brotcke, A., Weiss, D. S., Kim, C. C., Chain, P., Malfatti, S., Garcia, E. & Monack, D. M. (2006). Identification of MglA-regulated genes reveals novel virulence factors in Francisella tularensis. Infect Immun 74, 6642-6655.
7. Chamberlain, R. E. (1965). Evaluation of live tularemia vaccine prepared in a chemically defined medium. Appl Microbiol 13, 232-235.
8. Checroun, C., Wehrly, T. D., Fischer, E. R., Hayes, S. F. & Celli, J. (2006). Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proc Natl Acad Sci U S A 103, 14578-14583.
9. Chevalier, C., Thiberge, J. M., Ferrero, R. L. & Labigne, A. (1999). Essential role of Helicobacter pylori γ-glutamyltranspeptidase for the colonization of the gastric mucosa of mice. Mol Microbiol 31, 1359-1372.
10. Clemens, D. L., Lee, B. Y. & Horwitz, M. A. (2004). Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect Immun 72, 3204-3217.
11. Conlan, J. W. & Oyston, P. C. (2007). Vaccines against Francisella tularensis. Ann N Y Acad Sci 1105, 325-350.
12. Dennis, D. T., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Friedlander, A. M., Hauer, J. & other authors (2001). Tularemia as a biological weapon: medical and public health management. JAMA 285, 2763-2773.
13. Dorofe'ev, K. A. (1947). Classification of the causative agent of tularemia. Symp Res Works Inst Epidemiol Mikrobiol Chita 1, 170-180.
14. Euzéby, J. P. (1997). List of Bacterial Names with Standing in Nomenclature: a folder available on the Internet. Int J Syst Bacteriol 47, 590-592.
15. Forsman, M., Sandström, G. & Sjöstedt, A. (1994). Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int J Syst Bacteriol 44, 38-46.
16. Gill, V. & Cunha, B. A. (1997). Tularemia pneumonia. Semin Respir Infect 12, 61-67.
17. Golovliov, I., Ericsson, M., Sandström, G., Tärnvik, A. & Sjöstedt, A. (1997). Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect Immun 65, 2183-2189.
18. Golovliov, I., Sjöstedt, A., Mokrievich, A. & Pavlov, V. (2003). A method for allelic replacement in Francisella tularensis. FEMS Microbiol Lett 222, 273-280.
19. Gong, M. & Ho, B. (2004). Prominent role of gamma-glutamyltranspeptidase on the growth of Helicobacter pylori. World J Gastroenterol 10, 2994-2996.
20. Green, M., Choules, G., Rogers, D. & Titball, R. W. (2005). Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. Vaccine 23, 2680-2686.
21. Gregus, Z., Stein, A. F. & Klaassen, C. D. (1987). Effect of inhibition of gamma-glutamyltranspeptidase on biliary and urinary excretion of glutathione-derived thiols and methylmercury. J Pharmacol Exp Ther 242, 27-32.
22. Hesselbrock, W. & Foshay, L. (1945). The morphology of Bacterium tularense. J Bacteriol 49, 209-231.
23. Hollis, D.G.,Weaver, R. E., Steigerwalt, A. G.,Wenger, J. D.,Moss, C.W. & Brenner, D. J. (1989). Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol 27, 1601-1608.
24. Hubálek, M., Hernychová, L., Brychta, M., Lenco, J., Zechovská, J. & Stulík, J. (2004). Comparative proteome analysis of cellular proteins extracted from highly virulent Francisella tularensis ssp. tularensis and less virulent F. tularensis ssp. holarctica and F. tularensis ssp. mediaasiatica. Proteomics 4, 3048-3060.
25. Huseby, N. E. & Strömme, J. H. (1974). Practical points regarding routine determination of γ-glutamyl transferase (γ-GT) in serum with a kinetic method at 37 uC. Scand J Clin Lab Invest 34, 357-363.
26. Ikeda, Y., Fujii, J., Anderson, M. E., Taniguchi, N. & Meister, A. (1995). Involvement of Ser-451 and Ser-452 in the catalysis of human gamma-glutamyl transpeptidase. J Biol Chem 270, 22223-22228.
27. Kadzhaev, K., Zingmark, C., Golovliov, I., Bolanowski, M., Shen, H., Conlan, W. & Sjöstedt, A. (2009). Identification of genes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection model. PLoS ONE 4, e5463.
28. Lai, X. H., Golovliov, I. & Sjöstedt, A. (2004). Expression of IglC is necessary for intracellular growth and induction of apoptosis in murine macrophages by Francisella tularensis. Microb Pathog 37, 225-230.
29. LeButt, H. (2008). The construction and use of a Francisella tularensis DNA microarray. PhD thesis. Open University, Dstl, Salisbury, UK.
30. Masip, L., Veeravalli, K. & Georgiou, G. (2006). The many faces of glutathione in bacteria. Antioxid Redox Signal 8, 753-762.
31. McCoy, G. W. & Chapin, C. W. (1912). Further observations on a plague-like disease of rodents with a preliminary note on the causative agent, Bacterium tularensis. J Infect Dis 10, 61-72.
32. McGovern, K. J., Blanchard, T. G., Gutierrez, J. A., Czinn, S. J., Krakowka, S. & Youngman, P. (2001). γ-Glutamyltransferase is a Helicobacter pylori virulence factor but is not essential for colonization. Infect Immun 69, 4168-4173.
33. Michell, S. L., Dean, R. E., Eyles, J. E., Hartley, M. G., Waters, E., Prior, J. L., Titball, R. W. & Oyston, P. C. (2010). Deletion of the Bacillus anthracis capB homologue in Francisella tularensis subspecies tularensis generates an attenuated strain that protects mice against virulent tularaemia. J Med Microbiol 59, 1275-1284.
34. Milne, T. S., Michell, S. L., Diaper, H., Wikström, P., Svensson, K., Oyston, P. C. & Titball, R. W. (2007). A 55 kDa hypothetical membrane protein is an iron-regulated virulence factor of Francisella tularensis subsp. novicida U112. J Med Microbiol 56, 1268-1276.
35. Mörner, T. (1992). The ecology of tularaemia. Rev Sci Tech 11, 1123-1130.
36. Olsufiev, N. G., Emelyanova, O. S. & Dunayeva, T. N. (1959). Comparative study of strains of B. tularense in the old and new world and their taxonomy. J Hyg Epidemiol Microbiol Immunol 3, 138-149.
37. Olsufjev, N. G. & Meshcheryakova, I. S. (1982). Infraspecific taxonomy of tularemia agent Francisella tularensis McCoy et Chapin. J Hyg Epidemiol Microbiol Immunol 26, 291-299.
38. Owens, R. A. & Hartman, P. E. (1986). Glutathione: a protective agent in Salmonella typhimurium and Escherichia coli as measured by mutagenicity and by growth delay assays. Environ Mutagen 8, 659-673.
39. Oyston, P. C. & Griffiths, R. (2009). Francisella virulence: significant advances, ongoing challenges and unmet needs. Expert Rev Vaccines 8, 1575-1585.
40. Pechous, R. D., McCarthy, T. R., Mohapatra, N. P., Soni, S., Penoske, R. M., Salzman, N. H., Frank, D. W., Gunn, J. S. & Zahrt, T. C. (2008). A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge. PLoS ONE 3, e2487.
41. Pechous, R. D., McCarthy, T. R. & Zahrt, T. C. (2009). Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol Mol Biol Rev 73, 684-711.
42. Qin, A. & Mann, B. J. (2006). Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. BMC Microbiol 6, 69.
43. Qin, A., Scott, D. W. & Mann, B. J. (2008). Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence. Infect Immun 76, 3086-3092.
44. Quarry, J. E., Isherwood, K. E., Michell, S. L., Diaper, H., Titball, R. W. & Oyston, P. C. (2007). A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice. Vaccine 25, 2011-2018.
45. Riccillo, P. M., Muglia, C. I., de Bruijn, F. J., Roe, A. J., Booth, I. R. & Aguilar, O. M. (2000). Glutathione is involved in environmental stress responses in Rhizobium tropici, including acid tolerance. J Bacteriol 182, 1748-1753.
46. Sambrook, J. & Russell, D. W. (2001). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
47. Shen, H., Harris, G., Chen, W., Sjöstedt, A., Ryden, P. & Conlan, W. (2010). Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy. PLoS ONE 5, e13349.
48. Simon, R., Priefer, U. & Pühler, A. (1983). A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Nat Biotechnol 1, 784-791.
49. Sjöstedt, A. (2006). Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. Microbes Infect 8, 561-567.
50. Takahashi, H., Hirose, K. & Watanabe, H. (2004). Necessity of meningococcal γ-glutamyl aminopeptidase for Neisseria meningitides growth in rat cerebrospinal fluid (CSF) and CSF-like medium. J Bacteriol 186, 244-247.
51. Tate, S. S. & Meister, A. (1981). γ-Glutamyl transpeptidase: catalytic, structural and functional aspects. Mol Cell Biochem 39, 357-368.
52. Tempel, R., Lai, X. H., Crosa, L., Kozlowicz, B. & Heffron, F. (2006). Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect Immun 74, 5095-5105.
53. Thomas, R. M., Titball, R. W., Oyston, P. C., Griffin, K., Waters, E., Hitchen, P. G., Michell, S. L., Grice, I. D., Wilson, J. C. & Prior, J. L. (2007). The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect Immun 75, 371-378.
54. Thomas, R. M., Twine, S. M., Fulton, K. M., Tessier, L., Kilmury, S. L. N., Ding, W., Harmer, N., Michell, S. L., Oyston, P. C. F. & Prior, J. L. (2011). Glycosylation of DsbA in Francisella tularensis subspecies tularensis. J Bacteriol 193, 5498-5509.
55. Tigertt, W. D. (1962). Soviet viable Pasteurella tularensis vaccines. A review of selected articles. Bacteriol Rev 26, 354-373.
56. Twine, S., Byström, M., Chen, W., Forsman, M., Golovliov, I., Johansson, A., Kelly, J., Lindgren, H., Svensson, K. & other authors (2005). A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun 73, 8345-8352.
57. Wills, E. D. (1966). Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99, 667-676.
58. Xu, K. & Strauch, M. A. (1996). Identification, sequence, and expression of the gene encoding γ-glutamyltranspeptidase in Bacillus subtilis. J Bacteriol 178, 4319-4322.
59. Zarnowski, R., Cooper, K. G., Brunold, L. S., Calaycay, J. & Woods, J. P. (2008). Histoplasma capsulatum secreted γ-glutamyltransferase reduces iron by generating an efficient ferric reductant. Mol Microbiol 70, 352-368.